Nebivolol (HCl)
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Nebivolol (HCl) is a selective beta-1 antagonist, that is used in the management of hypertension.
Indications
Nebivolol (HCl) is primarily indicated in conditions like Essential hypertension, Heart failure.
Contraindications
Nebivolol (HCl) is contraindicated in conditions like Hypersensitivity, Cardiogenic shock, Severe hepatic impairment, Heart block, Decompensated heart failure.
Side Effects
The severe or irreversible adverse effects of Nebivolol (HCl), which give rise to further complications include Postural hypotension. The signs and symptoms that are produced after the acute overdosage of Nebivolol (HCl) include Bradycardia, Hypotension, Bronchospasm, Cardiac insufficiency. The symptomatic adverse reactions produced by Nebivolol (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Tiredness, Headache, Fatigue, Skin rashes, Depression, Fluid retention, Sexual dysfunction, Nightmares, Shortening of breath, Dry eye, Skin rashes.
Warnings
It should be used carefully in diabetic patients and patients with kidney or liver disease. Nebivolol medicine may reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how Nebivolol affects you and you are sure it won't affect your performance. Problems such as slow heartbeat, low blood pressure, and trouble in breathing have been reported in nursing babies. Mothers who are taking beta-blockers including Nebivolol and who wish to breast-feed should discuss this with their doctor.
High Risk Groups
Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
5 mg/day (5 (5)) As recommended. PO —
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Nebivolol (HCl) was found.
Storage
No storage information is recorded for this medicine yet.